These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 20104743

  • 1. [Gene characterization of E6 and E7 gene of human papillomavirus of 15 cervical cancer in Beijing].
    Ren Z, Wu HW, Song J.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):88-90. PubMed ID: 20104743
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas.
    Vaeteewoottacharn K, Jearanaikoon P, Ponglikitmongkol M.
    Anticancer Res; 2003 Apr; 23(2C):1927-31. PubMed ID: 12820481
    [Abstract] [Full Text] [Related]

  • 5. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers.
    Choi BS, Kim SS, Yun H, Jang DH, Lee JS.
    J Med Virol; 2007 Apr; 79(4):426-30. PubMed ID: 17311337
    [Abstract] [Full Text] [Related]

  • 6. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D.
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.
    Chang CH, Chen TH, Hsu RC, Chou PH, Yang JJ, Hwang GY.
    J Clin Virol; 2005 Jan; 32(1):33-7. PubMed ID: 15572004
    [Abstract] [Full Text] [Related]

  • 9. [Sequence polymorphism of human papillomavirus type 16 E7 in cervical cancer].
    Liu X, Liu GB, Pang ZJ, Xing FQ.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1272-5. PubMed ID: 16234107
    [Abstract] [Full Text] [Related]

  • 10. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
    Wang JT, Ding L, Gao ES, Cheng YY.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
    [Abstract] [Full Text] [Related]

  • 11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB.
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China.
    Wu Y, Chen Y, Li L, Yu G, He Y, Zhang Y.
    J Gen Virol; 2006 May; 87(Pt 5):1181-1188. PubMed ID: 16603519
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA, Jordanova ES, Kenter GG, Peters AA, Corver WE, Trimbos JB, Fleuren GJ.
    Clin Cancer Res; 2007 Jan 01; 13(1):132-8. PubMed ID: 17200347
    [Abstract] [Full Text] [Related]

  • 17. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women.
    Song YS, Kee SH, Kim JW, Park NH, Kang SB, Chang WH, Lee HP.
    Gynecol Oncol; 1997 Aug 01; 66(2):275-81. PubMed ID: 9264576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Drijfhout JW, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, van der Burg SH, Melief CJ.
    Clin Cancer Res; 2008 Jan 01; 14(1):169-77. PubMed ID: 18172268
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.